Phase II study of trifluridine/tipiracil (TAS-102) therapy in elderly patients with colorectal cancer (T-CORE1401): geriatric assessment tools and plasma drug concentrations as possible predictive biomarkers.
Takahashi M, Sakamoto Y, Ohori H, Tsuji Y, Kuroki M, Kato S, Otsuka K, Komine K, Takahashi M, Takahashi S, Shirota H, Ouchi K, Takahashi Y, Imai H, Shibata H, Yoshioka T, Tanaka M, Yamaguchi H, Yamaguchi T, Shimodaira H, Ishioka C.
Takahashi M, et al. Among authors: kuroki m.
Cancer Chemother Pharmacol. 2021 Sep;88(3):393-402. doi: 10.1007/s00280-021-04277-3. Epub 2021 May 24.
Cancer Chemother Pharmacol. 2021.
PMID: 34028598
Free PMC article.
Clinical Trial.